News
Innovent Biologics, Inc. ('Innovent') (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, ...
Providers of compounded obesity drugs are finding—for now—a new way into the booming market by tweaking formulations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results